Great Point Partners’s Karuna Therapeutics, Inc. Common Stock KRTX Stock Holding History

Great Point Partners’s Portfolio KRTX Stock Details KRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-30,250	Closed	-$9.57M	–	44
2023 Q4	$9.57M	Sell	30,250 -30,250	-50%	-$5.88M	1.63%	22
2023 Q3	$10.2M	Buy	+60,500	New	+$11.4M	1.86%	25
2022 Q3	–	Sell	-149,000	Closed	-$18.9M	–	48
2022 Q2	$18.9M	Buy	+149,000	New	+$17.1M	4.52%	8

Other funds holding KRTX

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Sachetta Lynnfield, Massachusetts $206M AUM 26.19% 1-Year Est. Return

Great Point Partners's KRTX Position: Q1 2024 in Review

Great Point Partners sold out of Karuna Therapeutics, Inc. Common Stock (KRTX) in Q1 2024, closing a stake of 30,250 shares — an estimated $9.57M sold.

Great Point Partners first reported a position in KRTX in Q2 2022 and held it in 3 quarters. The position peaked at $18.9M in Q2 2022. 2 funds tracked by Wall St. Rank hold KRTX as of Q1 2024.

Great Point Partners reported no remaining Karuna Therapeutics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
Great Point Partners sold 30,250 Karuna Therapeutics, Inc. Common Stock shares in Q1 2024, an estimated $9.57M.
Great Point Partners first reported a position in Karuna Therapeutics, Inc. Common Stock in Q2 2022 and held it in 3 quarters.
Great Point Partners's Karuna Therapeutics, Inc. Common Stock position peaked at $18.9M in Q2 2022.
2 funds tracked by Wall St. Rank held Karuna Therapeutics, Inc. Common Stock as of Q1 2024.

Based on Great Point Partners's 13F filing for Q1 2024, filed 15 May 2024.